Jennifer Chheda Ph.D., Gasper LaRosa, Shehla Wynne Ph.D. The Situation: The Biologics Price Competition and Innovation Act was considered in a November 2017 decision by the United States Court of ...

On November 13 th, in an opinion drafted by Judge Taranto, the Federal Circuit affirmed the Southern District Court of Florida’s judgment that Apotex’s biosimilar versions of Neulasta® and Neupogen® ...

Affidavits originating from a person with close links to the party concerned are of less probative value than third-party affidavits and must thus be supplemented by further objective evidence.

A retraction does not necessarily negate an earlier declaration. Retractions are looked upon with disfavor and do not automatically exclude the original statement or declaration. This is the general ...

The decision establishes a new tool to protect IP rights, particularly in the field of artistic property. Register for free to receive our newsletter, view leading trademark professionals in WTR 1000 ...